semaglutide tablet 3mg Rybelsus 3 mg Tablets for Type 2 Diabetes Management 1 receptor agonist). Dosing & Prescribing | RYBELSUS®

Guastello AD, Lieneman C, Bailey B, Munson M, Barthle-Herrera M, Higham M, Druskin L, McNeil CB

Pen-sharing poses a risk for transmission of blood-borne pathogens Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia

This is reported as a monitoring consideration documented in the literature, not as a directive

World J Stem Cells

doi: 10.3390/ijms25063385 109

Endocrinology (2004) 145:3,27388